Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3121-3129

  Crofton, P M ^a,b,d   Ahmed, S F ^b   Wade, J C ^b   Stephen, R ^b   Elmlinger, M W ^c   Ranke, M B ^c   Kelnar, C J H ^b   Wallace, W H B ^b  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d Department of Pediatric Biochemistry ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ANTINEOPLASTIC AGENT; ASPARAGINASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; COTRIMOXAZOLE; CYTARABINE; DAUNORUBICIN; DEOXYPYRIDINOLINE; ETOPOSIDE; FOLINIC ACID; GLUCOCORTICOID; GROWTH HORMONE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROCOLLAGEN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PYRIDINOLINE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE TURNOVER; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN METABOLISM; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEG LENGTH; LONGITUDINAL STUDY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENTS; BONE REMODELING; CHILD; CHILD, PRESCHOOL; COLLAGEN; COLLAGEN TYPE I; HUMAN GROWTH HORMONE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LEUKEMIA, LYMPHOCYTIC, ACUTE; LONGITUDINAL STUDIES; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; PROSPECTIVE STUDIES;

EID: 0031741592     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3121     Document Type: Article

References (59)

1. Clayton PE, Shalet SM, Morris-Jones PH, Price DA. 1988 Growth in children treated for acute lymphoblastic leukaemia. Lancet. 1:460-462.
2. Möell C, Garwicz S, Marky I, Mellander L, Karlberg J. 1988 Growth in children treated for acute lymphoblastic leukemia with and without prophylactic cranial irradiation. Acta Paediatr Scand. 77:688-692.
3. Cicognani A, Cacciari E, Vecchi V, et al. 1988 Differential effects of 18- and 24-Gy cranial irradiation on growth rate and growth hormone release in children with prolonged survival after acute lymphocytic leukemia. Am J Dis Child. 142:1199-1202.
4. Hokken-Koelega ACS, Van Doorn JWD, Hählen K, et al. 1993 Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study. Pediatr Res. 33:577-582.
5. Thun-Hohenstein L, Frisch H, Schuster E. 1992 Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma. Horm Res. 37:91-95.
6. Wallace WHB, Kelnar CJH. 1996 The effect of chemotherapy on growth and endocrine function in childhood. Baillieres Clin Paediatr. 4:333-347.
7. Mohnike K, Dörffel W, Timme J, et al. 1997 Final height and puberty in 40 patients after antileukaemic treatment during childhood. Eur J Paediatr. 156:272-276.
8. Caruso-Nicoletti M, Mancuso M, Spadaro G, Dibenedetto SP, DiCataldo A, Schilir G. 1993 Growth and growth hormone in children during and after therapy for acute lymhoblastic leukaemia. Eur J Pediatr. 152:730-733.
9. Holm K, Nysom K, Hertz H, Müller J. 1994 Normal final height after treatment for acute lymhoblastic leukemia without irradiation. Acta Paediatr. 83:1287-1290.
10. Ahmed SF, Wallace WHB, Kelnar CJH. 1997 An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Horm Res. 48:178-183.
11. Sklar C, Mertens A, Walters, et al. 1993 Final height after treatment of acute lymphoblastic leukaemia: a comparison of no cranial irradiation, 1800 cGy and 2400 cGy cranial irradiation. J Pediatr. 123:59-64.
12. Atkinson SA, Fraher L, Gundberg CM, Andrew M, Pai M, Barr RD. 1989 Mineral homeotasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr. 114:793-800.
13. Halton JM, Atkinson SA, Fraher L, et al. 1996 Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukaemia. J Bone Miner Res. 11:1774-1783.
14. Ahmed SF, Wallace WHB, Crofton PM, Wardhaugh B, Magowan R, Kelnar CJH. Short-term changes in lower leg length in children treated for acute lymphoblastic leukaemia. J Pediatr Endocrinol Metab. In press.
15. Ahmed SF, Wallace WHB, Kelnar CJH. 1995 Knemometry in childhood: a study to compare the precision of two different techniques. Ann Hum Biol. 22:247-252.
16. Melkko J, Niemi S, Risteli L, Risteli J. 1990 Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 36:1328-1332.
17. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. 1993 Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 39:635-640.
18. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. 1988 Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem. 34:715-718.
19. Peaston RT, Cooper J. 1986 Affinity electrophoresis of alkaline phosphatase isoenzymes. Clin Chem. 32:235-236.
20. Pratt DA, Daniloff Y, Duncan A, Robins SP. 1992 Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem. 207:168-175.
21. Black D, Duncan A, Robins SP. 1988 Quantitative analysis of the pyrinium crosslinks of collagen in urine using ion-paired reversed-phase high performance liquid chromatography. Anal Biochem. 169:197-203.
22. Blum WF, Breier BH. 1994 Radioimmunoassay for IGFs and IGFBPs. Growth Regul. 4(Suppl 1):11-19.
23. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel JH, Bierich JR. 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1297.
24. Elmlinger MW, Wimmer K, Biemer E, et al. 1996 Insulin-like growth factor binding protein 2 (IGFBP-2) is differentially expressed in leukaemic T- and B-cell lines. Growth Regul. 6:152-157.
25. Kratzsch J, Schreiber G, Selisko T, Keller E, Pfalum CD, Strasburger CJ. 1997 Measurement of serum exon-3-retaining growth hormone binding protein in children and adolescents by radioimmunoassay. Horm Res. 48:252-257.
26. Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA. 1995 Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 73:17-24.
27. Crofton PM, Wade JC, Taylor MRH, Holland CV. 1997 Serum concentrations of the carboxyterminal propeptide of type I procollagen, the aminoterminal propeptide of type III procollagen, the cross-linked carboxyterminal telopeptide of type I collagen and their interrelationships in schoolchildren. Clin Chem. 43:1577-1581.
28. Blum WF. 1996 Insulin-like growth factors and their binding proteins. In: Ranke MB, ed. Diagnostics of endocrine function in children and adolescents. Heidelberg, Leipzig: Barth, Edition J&J; 190-218.
29. Crofton PM. 1992 Wheat-germ lectin affinity electrophoresis for alkaline phosphatase isoforms in children: age-dependent reference ranges and changes in liver and bone disease. Clin Chem. 38:663-670.
30. Tamminga RYJ, Kamps WA, Drayer NM, Humphrey GB. 1992 Longitudinal anthropometric study in children with acute lymphoblastic leukaemia. Acta Paediatr. 81:61-65.
31. Ragab AH, Frech RS, Vietti TJ. 1970 Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer. 25:580-585.
32. Nesbit M, Krivit W, Heyn R, Sharp H. 1976 Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems. Cancer. 37:1048-1054.
33. Stanisavljevic S, Babcock AL. 1977 Fractures in children treated with methotrexate for leukemia. Clin Orthop. 125:139-142.
34. Schwartz AM, Leonidas JC. 1984 Methotrexate osteopathy. Skel Radiol. 11:13-16.
35. Calvo MS, Eyre DR, Gundberg CM. 1996 Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev. 17:333-368.
36. Jackson Smith W, Jeong Nam T, Underwood LE, Busby WH, Celnicker A, Clemmons DR. 1993 Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab. 77:1294-1299.
37. Rosen CJ, Donahue LR, Hunter SJ. 1994 Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med. 206:83-102.
38. Kelley KM, Oh Y, Gargosky SE, et al. 1996 Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol. 28:619-637.
39. Berglund G, Karlberg J, Marky I, Mellander L. 1985 A longitudinal study of growth in children with acute lymphoblastic leukemia. Acta Paediatr Scand. 74:530-533.
40. Sorva R, Kivivuori S-M, Turpeinen M, et al. 1997 Very low rate of type I collagen synthesis and degradation in newly diagnosed children with acute lymphoblastic leukemia. Bone. 20:139-143.
41. Mohnike KL, Kluba U, Mittler U, Aumann V, Vorwerk P, Blum WF. 1996 Serum levels of insulin-like growth factor-I, - II and insulin-like growth factor binding proteins-2 and -3 in children with acute lymphoblastic leukaemia. Eur J Pediatr. 155:81-86.
42. Dahn MS, Lange MP, Jacobs LA. 1988 Insulin-like growth factor 1 production is inhibited in human sepsis. Arch Surg. 123:1409-1414.
43. Müller HL, Oh Y, Lehrnbecher T, Blum WF, Rosenfeld RG. 1994 Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab. 79:428-434.
44. Wiklund TA, Blomqvist CP, Risteli L, Risteli J, Elomaa I. 1993 Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas. J Cancer Res Clin Oncol. 119:160-164.
45. Ahmed SF, Wardhaugh BW, Duff J, Wallace WHB, Kelnar CJH. 1996 The relationship between short-term changes in weight and lower leg length in children and young adults. Ann Hum Biol. 23:159-162.
46. Delaney AM, Dong Y, Canalis E. 1994 Mechanisms of glucocorticoid action in bone cells. J Cell Biochem. 56:295-302.
47. Canalis E. 1996 Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab. 81:3441-3447.
48. Hill DJ. 1981 Effects of cortisol on cell proliferation and proteoglycan synthesis and degradation in cartilage zones of the calf costochondral growth plate in vitro with and without rat plasma somatomedin activity. J Endocrinol. 88:425-435.
49. Robson H, Anderson E, Isaksson O, Eden T, Shalet SM. 1997 A comparison of the sensitivity of growth plate chondrocytes in vitro to the glucocorticoids dexamethasone and prednisolone. Horm Res. 48(Suppl 2):78.
50. Wolthers OD, Juul A, Hansen M, Müller J, Pederson S. 1994 The insulin-like growth factor axis and collagen turnover during prednisolone treatment. Arch Dis Child. 71:409-413.
51. Birkebæk NH, Esberg G, Andersen K, Wolthers O, Hassager C. 1995 Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child. 73:524-527.
52. Stein GS, Lian JB, Owen TA. 1990 Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4:3111-3123.
53. Miell JP, Buchanan CR, Norman MR, Maheshwari HG, Blum WF. 1994 The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. J Endocrinol. 142:547-554.
54. Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB. 1992 Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol. 263:E489-E492.
55. Ohlsson C, Isgaard J, Tönell J, Nilsson A, Isaksson OGP, Lindahl A. 1993 Endocrine regulation of longitudinal bone growth. Acta Paediatr Scand. 82(Suppl 391):33-40.
56. Risteli J, Sogaard H, Oikarinen A, Risteli L, Karvonen J, Zachariae H. 1988 Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis. Br J Dermatol. 119:321-325.
57. May KP, West SG, McDermott MT, Huffer WE. 1994 The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum. 37:201-206.
58. Wheeler DL, Vander Griend RA, Wronski TJ, Miller GJ, Keith EE, Graves JE. 1995 The short- and long-term effects of methotrexate on the rat skeleton. Bone. 16:215-221.
59. Moëll C, Garwicz S. 1995 High-dose methotrexate causes short-term suppression of growth in rabbits. Acta Paediatr. 84:1237-1240.